• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高新冠疫苗接种率对老龄化人口的影响:使用反事实模型估计西班牙巴斯克地区避免的住院和死亡人数。

Impact of High Covid-19 Vaccination Rate in an Aging Population: Estimating Averted Hospitalizations and Deaths in the Basque Country, Spain Using Counterfactual Modeling.

机构信息

BCAM-Basque Center for Applied Mathematics, Alameda Mazarredo 14, Bilbao, Basque Country, 48009, Spain.

Preventive Medicine and Public Health Department, University of the Basque Country (UPV/EHU), Leioa, Basque Country, Spain.

出版信息

J Epidemiol Glob Health. 2024 Sep;14(3):1289-1299. doi: 10.1007/s44197-024-00286-6. Epub 2024 Aug 26.

DOI:10.1007/s44197-024-00286-6
PMID:39186212
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11442822/
Abstract

COVID-19 vaccines have demonstrated significant efficacy in reducing severe symptoms and fatalities, although their effectiveness in preventing transmission varies depending on the population's age profile and the dominant variant. This study evaluates the impact of the COVID-19 vaccination campaign in the Basque Country region of Spain, which has the fourth highest proportion of elderly individuals worldwide. Using epidemiological data on hospitalizations, ICU admissions, fatalities, and vaccination coverage, we calibrated four versions of an ordinary differential equations model with varying assumptions on the age structure and transmission function. Counterfactual no-vaccine scenarios were simulated by setting the vaccination rate to zero while all other parameters were held constant. The initial vaccination rollout is estimated to have prevented 46,000 to 75,000 hospitalizations, 6,000 to 11,000 ICU admissions, and 15,000 to 24,000 deaths, reducing these outcomes by 73-86%. The most significant impact occurred during the third quarter of 2021, coinciding with the Delta variant's dominance and a vaccination rate exceeding 60%. Sensitivity analysis revealed that vaccination coverage had a more substantial effect on averted outcomes than vaccine efficacy. Overall, the vaccination campaign in the Basque Country significantly reduced severe COVID-19 outcomes, aligning with global estimates and demonstrating robustness across different modeling approaches.

摘要

COVID-19 疫苗在降低重症症状和死亡率方面表现出显著的效果,但其在预防传播方面的效果因人群的年龄结构和主要变异株而异。本研究评估了 COVID-19 疫苗接种运动在西班牙巴斯克地区的影响,该地区是全球老年人比例第四高的地区。利用关于住院、重症监护病房(ICU)入院、死亡和疫苗接种覆盖率的流行病学数据,我们使用了四个不同的常微分方程模型版本,这些模型对年龄结构和传播函数的假设不同。通过将疫苗接种率设置为零,同时保持所有其他参数不变,模拟了没有疫苗的反事实情况。初步的疫苗接种推出估计预防了 46000 至 75000 例住院、6000 至 11000 例 ICU 入院和 15000 至 24000 例死亡,将这些结果降低了 73-86%。最大的影响发生在 2021 年第三季度,恰逢 Delta 变异株的主导地位和疫苗接种率超过 60%。敏感性分析表明,疫苗接种覆盖率对避免的结果的影响比疫苗效力更大。总体而言,巴斯克地区的疫苗接种运动显著降低了严重 COVID-19 的结果,与全球估计一致,并在不同的建模方法中表现出稳健性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3241/11442822/37556d5244ac/44197_2024_286_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3241/11442822/43f35dce074a/44197_2024_286_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3241/11442822/d5fa2a8b20a4/44197_2024_286_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3241/11442822/ff81aafb47af/44197_2024_286_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3241/11442822/9d43a93a83d7/44197_2024_286_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3241/11442822/37556d5244ac/44197_2024_286_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3241/11442822/43f35dce074a/44197_2024_286_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3241/11442822/d5fa2a8b20a4/44197_2024_286_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3241/11442822/ff81aafb47af/44197_2024_286_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3241/11442822/9d43a93a83d7/44197_2024_286_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3241/11442822/37556d5244ac/44197_2024_286_Fig5_HTML.jpg

相似文献

1
Impact of High Covid-19 Vaccination Rate in an Aging Population: Estimating Averted Hospitalizations and Deaths in the Basque Country, Spain Using Counterfactual Modeling.高新冠疫苗接种率对老龄化人口的影响:使用反事实模型估计西班牙巴斯克地区避免的住院和死亡人数。
J Epidemiol Glob Health. 2024 Sep;14(3):1289-1299. doi: 10.1007/s44197-024-00286-6. Epub 2024 Aug 26.
2
Direct impact of COVID-19 vaccination in Chile: averted cases, hospitalizations, ICU admissions, and deaths.智利新冠肺炎疫苗接种的直接影响:避免发病、住院、入住 ICU 和死亡。
BMC Infect Dis. 2024 May 3;24(1):467. doi: 10.1186/s12879-024-09304-1.
3
The impact of the COVID-19 vaccination programme on symptomatic and severe SARS-CoV-2 infection during a period of Omicron variant dominance in Ireland, December 2021 to March 2023.2021 年 12 月至 2023 年 3 月,在奥密克戎变异株主导期间,爱尔兰 COVID-19 疫苗接种计划对有症状和严重 SARS-CoV-2 感染的影响。
Euro Surveill. 2024 Jul;29(28). doi: 10.2807/1560-7917.ES.2024.29.28.2300697.
4
COVID-19 Vaccination and Incidence of Pediatric SARS-CoV-2 Infection and Hospitalization.新冠病毒疫苗接种与儿童感染新冠病毒及住院的发生率
JAMA Netw Open. 2024 Apr 1;7(4):e247822. doi: 10.1001/jamanetworkopen.2024.7822.
5
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.非药物干预措施、疫苗接种和 SARS-CoV-2 德尔塔变异株在英国:一项数学建模研究。
Lancet. 2021 Nov 13;398(10313):1825-1835. doi: 10.1016/S0140-6736(21)02276-5. Epub 2021 Oct 28.
6
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.在以色列全国范围内使用辉瑞-生物科技公司的 BNT162b2 mRNA COVID-19 疫苗进行疫苗接种运动,以预防感染、住院和死亡:一项回顾性监测研究。
Lancet Infect Dis. 2022 Mar;22(3):357-366. doi: 10.1016/S1473-3099(21)00566-1. Epub 2021 Sep 22.
7
A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran.定量评估疫苗推出速度和覆盖率对降低死亡率的影响:来自伊朗 COVID-19 疫情前 2 年的见解。
BMC Med. 2023 Nov 13;21(1):429. doi: 10.1186/s12916-023-03127-8.
8
Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.模拟 COVID-19 疫苗接种和非药物干预措施与感染、住院和死亡的关联。
JAMA Netw Open. 2021 Jun 1;4(6):e2110782. doi: 10.1001/jamanetworkopen.2021.10782.
9
Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021.美国 2020 年 12 月至 2021 年 9 月,疫苗接种者预防 COVID-19 感染、住院和死亡人数的估计数。
JAMA Netw Open. 2022 Jul 1;5(7):e2220385. doi: 10.1001/jamanetworkopen.2022.20385.
10
High vaccine effectiveness against severe COVID-19 outcomes and population preventable fraction during the Omicron era in Luxembourg: A nationwide retrospective risk factor analysis.在卢森堡的奥密克戎时代,疫苗对严重 COVID-19 结局和人群可预防分数的高有效性:一项全国性的回顾性风险因素分析。
Vaccine. 2024 Sep 17;42(22):126011. doi: 10.1016/j.vaccine.2024.05.059. Epub 2024 Jun 1.

本文引用的文献

1
Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan.日本使用 BNT162b2 进行 COVID-19 加强针接种的成本效益分析。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):349-361. doi: 10.1080/14760584.2024.2323133. Epub 2024 Mar 5.
2
Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study.基于性别、合并症和社会经济地位的 COVID-19 疫苗成本效益分析:一项人群研究。
Pharmacoeconomics. 2024 Feb;42(2):219-229. doi: 10.1007/s40273-023-01326-y. Epub 2023 Nov 1.
3
Cost-effectiveness of COVID-19 vaccination: A systematic review.
COVID-19 疫苗接种的成本效益:系统评价。
J Evid Based Med. 2023 Jun;16(2):152-165. doi: 10.1111/jebm.12525. Epub 2023 Apr 26.
4
The effect of mixed vaccination rollout strategy: A modelling study.混合疫苗接种策略的效果:一项建模研究。
Infect Dis Model. 2023 Jun;8(2):318-340. doi: 10.1016/j.idm.2023.03.002. Epub 2023 Mar 10.
5
Economic evaluation of COVID-19 vaccination: A systematic review.COVID-19 疫苗接种的经济评估:系统评价。
J Glob Health. 2023 Jan 14;13:06001. doi: 10.7189/jogh.13.06001.
6
Estimated COVID-19 severe cases and deaths averted in the first year of the vaccination campaign in Brazil: A retrospective observational study.巴西疫苗接种运动第一年避免的估计新冠重症病例和死亡:一项回顾性观察研究。
Lancet Reg Health Am. 2023 Jan;17:100418. doi: 10.1016/j.lana.2022.100418. Epub 2022 Dec 22.
7
Estimating the impact of implementation and timing of the COVID-19 vaccination programme in Brazil: a counterfactual analysis.评估巴西新冠疫苗接种计划的实施及时间安排的影响:一项反事实分析。
Lancet Reg Health Am. 2023 Jan;17:100397. doi: 10.1016/j.lana.2022.100397. Epub 2022 Nov 21.
8
Number of averted COVID-19 cases and deaths attributable to reduced risk in vaccinated individuals in Japan.日本因接种疫苗个体风险降低而避免的新冠病例数和死亡人数。
Lancet Reg Health West Pac. 2022 Nov;28:100571. doi: 10.1016/j.lanwpc.2022.100571. Epub 2022 Aug 11.
9
Evaluation of Effectiveness of Global COVID-19 Vaccination Campaign.全球 COVID-19 疫苗接种运动效果评估。
Emerg Infect Dis. 2022 Sep;28(9):1873-1876. doi: 10.3201/eid2809.212226. Epub 2022 Aug 1.
10
Modeling the initial phase of COVID-19 epidemic: The role of age and disease severity in the Basque Country, Spain.建模 COVID-19 疫情的初始阶段:西班牙巴斯克地区年龄和疾病严重程度的作用。
PLoS One. 2022 Jul 13;17(7):e0267772. doi: 10.1371/journal.pone.0267772. eCollection 2022.